Intra-Cellular Therapies Inc - ITCI - stock price prediction, stock price target, analyst ratings from 9 analysts

Intra-Cellular Therapies Inc has a share price target of US$ 132, revenue growth forecast of 39.9%, and profit growth estimate of 149.0% for FY25, based on top 9 analyst calls.